Page last updated: 2024-09-03

trisequens and Cardiovascular Diseases

trisequens has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Strandberg, TE; Tikkanen, MJ; Ylikorkala, O	1
Jensen, GF; McNair, P; Myrup, B	1

Trials

2 trial(s) available for trisequens and Cardiovascular Diseases

Article	Year
Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women. The American journal of cardiology, 2003, Jul-15, Volume: 92, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Middle Aged; Norethindrone; Reference Values; Risk Factors	2003
Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment. Archives of internal medicine, 1992, Volume: 152, Issue:11 Topics: Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholecalciferol; Cholesterol; Cholesterol, HDL; Denmark; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Risk Factors; Time Factors	1992

Article

Year

Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.

The American journal of cardiology, 2003, Jul-15, Volume: 92, Issue:2

Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Middle Aged; Norethindrone; Reference Values; Risk Factors

2003

Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment.

Archives of internal medicine, 1992, Volume: 152, Issue:11

Topics: Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholecalciferol; Cholesterol; Cholesterol, HDL; Denmark; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Risk Factors; Time Factors

1992